Dermatologicals in Ireland

In 2023, dermatologicals in Ireland saw only a slow retail current value growth rate, and this slow rate of increase is set to be maintained in 2024, demonstrating rather a stagnant performance. This category did not experience such significant turbulence over the pandemic period as products such as analgesics, or cough and cold remedies. Value sales in 2024 are expected to be only marginally higher than the pre-pandemic (2019) level.

The Dermatologicals in Ireland report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2019-2023, allowing you to identify the sectors driving growth. Forecasts to 2028 illustrate how the market is set to change.

Product coverage: Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Cold Sore Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Dermatologicals, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.

Data coverage: Market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

• Get a detailed picture of the Dermatologicals market;
• Pinpoint growth sectors and identify factors driving change;
• Understand the competitive environment, the market’s major players and leading brands;
• Use five-year forecasts to assess how the market is predicted to develop.